![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Publisher: Adis International
ISSN: 1173-5503
Source: PharmacoEconomics and Outcomes News, Vol.1, Iss.661, 2012-01, pp. : 11-11
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
NICE issues guidance on riluzole and Alzheimer's drugs
Inpharma, Vol. 1, Iss. 1272, 2001-01 ,pp. :
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
UK NICE issues guidance on temozolomide for brain cancer
PharmacoEconomics and Outcomes News, Vol. 1, Iss. 311, 2001-01 ,pp. :
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
UK NICE issues guidance on temozolomide for brain cancer
Inpharma, Vol. 1, Iss. 1286, 2001-01 ,pp. :
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
NICE issues draft guidance on abiraterone for prostate cancer
PharmacoEconomics and Outcomes News, Vol. 1, Iss. 647, 2012-01 ,pp. :
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
UK NICE issues guidance on lung cancer therapies
Inpharma, Vol. 1, Iss. 1294, 2001-01 ,pp. :